photo
Speaker

Christopher Missling, PhD

PRESIDENT AND CEO, ANAVEX LIFE SCIENCES CORP.
New York, New York, United States
Christopher U. Missling, PhD is President and CEO of Anavex Life Sciences Corp, has over 20 years of
healthcare industry experience within large pharmaceutical companies and the biotech industry. Prior to
joining Anavex, he served as the Chief Financial Officer of Curis and ImmunoGen. In addition, at Aventis
(now Sanofi), Christopher’s work is dedicated to finding potential cures for neurodegenerative and
neurodevelopmental diseases, like Alzheimer’s disease, and Parkinson’s disease, as well as, Rett
syndrome, Fragile X, Angelman’s syndrome, infantile spasms. Dr. Missling is working with his team to
advance new potential treatments through clinical trials by involving the respective advocacy groups
early on. Dr. Missling has an MS and PhD from the University of Munich in Chemistry and an MBA from
Northwestern University Kellogg School of Management and WHU Otto Beisheim School of
Management.
Speaking In
11:15 AM - 11:30 AM
Monday, February 10
Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders…
3:00 PM - 3:55 PM
Tuesday, February 11
In recent months, the exits of several large companies from the neuroscience space, optimistic…
Lyceum Complex